These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17929260)

  • 41. [Non-erosive reflux disease in endoscopy and histopathology].
    Błaszak A; Wojtuń S; Gil J; Wojtkowiak M; Dyrla P; Jałocha Ł; Dabek A; Kozłowski W
    Pol Merkur Lekarski; 2009 May; 26(155):399-402. PubMed ID: 19606683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of protease-activated-receptor 2 (PAR-2) in human esophageal mucosa.
    Inci K; Edebo A; Olbe L; Casselbrant A
    Scand J Gastroenterol; 2009; 44(6):664-71. PubMed ID: 19263271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Modified duodenal diversion in the treatment of esophagitis from bile reflux complicating an upper-pole gastrectomy].
    Elias D; Lasser P; Leclercq B; Nitenberg G
    J Chir (Paris); 1983 Nov; 120(11):651-3. PubMed ID: 6655015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of the complications of gastroesophageal reflux disease.
    Belhocine K; Galmiche JP
    Dig Dis; 2009; 27(1):7-13. PubMed ID: 19439954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of bile acids on cyclooxygenase-2 expression in a rat model of duodenoesophageal anastomosis.
    Hashimoto N
    World J Gastroenterol; 2014 Jun; 20(21):6541-6. PubMed ID: 24914375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
    Abraham SC; Wang H; Wang KK; Wu TT
    Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experimental study on the effect of bile, and bile and hydrochloric acid mixture on the esophageal mucosa.
    Manea GS; Lupuşoru C; Căruntu ID
    Rom J Morphol Embryol; 2009; 50(1):61-6. PubMed ID: 19221646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adiposity and columnar-lined esophagus.
    Lenglinger J; Eisler M; Riegler FM
    Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363
    [No Abstract]   [Full Text] [Related]  

  • 50. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic screening of a cell line model of esophageal carcinogenesis identifies cathepsin D and aldo-keto reductase 1C2 and 1B10 dysregulation in Barrett's esophagus and esophageal adenocarcinoma.
    Breton J; Gage MC; Hay AW; Keen JN; Wild CP; Donnellan C; Findlay JB; Hardie LJ
    J Proteome Res; 2008 May; 7(5):1953-62. PubMed ID: 18396902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adenocarcinoma of the gastroesophageal junction after bariatric surgery.
    Melstrom LG; Bentrem DJ; Salvino MJ; Blum MG; Talamonti MS; Printen KJ
    Am J Surg; 2008 Jul; 196(1):135-8. PubMed ID: 18417085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High risk of malignancy in familial Barrett's esophagus: presentation of one family.
    Munitiz V; Parrilla P; Ortiz A; Martinez-de-Haro LF; Yelamos J; Molina J
    J Clin Gastroenterol; 2008 Aug; 42(7):806-9. PubMed ID: 18385604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease.
    van Malenstein H; Farré R; Sifrim D
    Am J Gastroenterol; 2008 Apr; 103(4):1021-8. PubMed ID: 18076734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Barrett's esophagus in the esophageal remnant: a critical long-term complication of subtotal esophagectomy.
    D'Journo XB; Ferraro P; Martin J; Duranceau A
    Ann Surg Oncol; 2009 May; 16(5):1429; author reply 1430-1. PubMed ID: 19184232
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical outcome of esophageal cancer after distal gastrectomy: a prospective study.
    Li HH; Zhang QZ; Xu L; Hu JW
    Int J Surg; 2008 Apr; 6(2):129-35. PubMed ID: 18442806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors and gene expression in esophageal cancer.
    Xu XC
    Methods Mol Biol; 2009; 471():335-60. PubMed ID: 19109788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target.
    Abdel-Latif MM; Kelleher D; Reynolds JV
    J Surg Res; 2009 May; 153(1):172-80. PubMed ID: 18533190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.